CE: Cannabis Considerations in Pediatrics

Learning Objectives: Upon successful completion of this knowledge-based course pharmacists should be able to: Describe the possible indications for cannabis use in pediatric patients. Compare the risks and benefits of major cannabinoids THC and CBD in pediatric populations. Discuss the legal challenges to cannabis administration in pediatric populations. Faculty: James Cobb Scott, PhD Assistant Professor, University of Pennsylvania Melani Kane, PharmD Cannabis Pharmacist, ISCPh Christine Roussel, PharmD, BCOP Director of Pharmacy, Doylestown Hospital Faculty Disclosure: Dr. Kane reports that she is a consultant to Iowa Cannabis Company, Mandala Wellness, and Strain Connect and a former pharmacist at Minnesota Medical Solutions. CEI has taken appropriate action for conflict resolution, including external peer review. Dr. Scott and Dr. Roussel do not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course. CPE Credit ACPE CEI is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. UAN: 0107-9999-23-180-H01-T | 0.2 CEUs/ 2 Hrs | On Demand Release Date: May 1, 2023 On Demand Expiration Date: May 1, 2026 ON DEMAND: To obtain 2.0 contact hours of continuing pharmacy education credit (0.2 CEU), participants must participate in the on-demand course, and complete the exam and evaluation. Once successfully completed, click Submit. The CPE Statement of Credit can then be accessed on CPE Monitor, www.MyCPEMonitor.net. Course Format: Live and on-demand. Financial Support: None. Course Fee: This course is available for free for ISCPh members.